Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name (Ascending) Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00015-3030-20 00015-3030 Lomustine Ceenu 10.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Dec. 15, 2008 April 15, 2016 No Longer Used
00015-3031-20 00015-3031 Lomustine Ceenu 40.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Dec. 15, 2008 April 15, 2016 No Longer Used
00015-3032-20 00015-3032 Lomustine Ceenu Chemotherapy Alkylating Agent Nitrosourea Oral Dec. 15, 2008 June 30, 2014 No Longer Used
58181-3030-05 58181-3030 Lomustine Lomustine 10.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral July 29, 2014 Jan. 14, 2016 No Longer Used
58181-3031-05 58181-3031 Lomustine Lomustine 40.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral July 29, 2014 Jan. 14, 2016 No Longer Used
58181-3032-05 58181-3032 Lomustine Lomustine 100.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Sept. 27, 2013 Jan. 14, 2016 No Longer Used
58181-3043-05 58181-3043 Lomustine Gleostine 5.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Nov. 5, 2015 June 30, 2018 No Longer Used
58181-3040-05 58181-3040 Lomustine Gleostine 10.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Aug. 18, 2014 In Use
58181-3041-05 58181-3041 Lomustine Gleostine 40.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Aug. 18, 2014 In Use
58181-3042-05 58181-3042 Lomustine Gleostine 100.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Aug. 18, 2014 In Use
00069-0227-01 00069-0227 Lorlatinib Lorbrena 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ALK/ROS1 Oral Nov. 19, 2018 In Use
00069-0231-01 00069-0231 Lorlatinib Lorbrena 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ALK/ROS1 Oral Nov. 19, 2018 In Use
63539-0927-01 63539-0927 Lorlatinib Lorbrena 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor ALK/ROS1 Oral Jan. 3, 2023 In Use
68727-0712-01 68727-0712 Lurbinectedin ZEPZELCA 0.5 mg/mL Chemotherapy Alkylating Agent Adduct Forming Agent Intravenous June 15, 2020 In Use
59572-0711-01 59572-0711 Luspatercept REBLOZYL 25.0 mg/1 Ancillary Therapy Erythropoiesis-Stimulating Agent Subcutaneous Nov. 8, 2019 In Use
59572-0775-01 59572-0775 Luspatercept Reblozyl 75.0 mg/1 Immunotherapy Erythropoiesis-Stimulating Agent Subcutaneous Nov. 8, 2019 In Use
69488-0003-01 69488-0003 Lutetium Lu 177 dotatate Lutathera 10.0 mCi/mL Chemotherapy Radiopharmaceutical Somatostatin Analog Intravenous Jan. 26, 2018 In Use
69488-0010-61 69488-0010 Lutetium Lu 177 vipivotide tetraxetan PLUVICTO 27.0 mCi/mL Radiopharmaceutical Radiopharmaceutical PSMA Intravenous March 23, 2022 In Use
64764-0800-28 64764-0800 MARIBAVIR Livtencity 200.0 mg/1 Ancillary Therapy Miscellaneous Agent CMV Antiviral Oral Nov. 23, 2021 In Use
64764-0800-56 64764-0800 MARIBAVIR Livtencity 200.0 mg/1 Ancillary Therapy Miscellaneous Agent CMV Antiviral Oral Nov. 23, 2021 In Use
50742-0477-01 50742-0477 MELPHALAN HYDROCHLORIDE MELPHALAN HYDROCHLORIDE Chemotherapy Alkylating Agent Nitrogen Mustard Feb. 18, 2020 In Use
42254-0110-30 42254-0110 METHOTREXATE Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Dec. 7, 1953 In Use
50090-0294-09 50090-0294 METHOTREXATE Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral June 29, 2016 Jan. 31, 2021 In Use
55289-0924-30 55289-0924 METHOTREXATE Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Oct. 23, 2009 Aug. 3, 2018 No Longer Used
66336-0338-21 66336-0338 METHOTREXATE Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Dec. 7, 1953 In Use

Found 10,000 results in 8 milliseconds — Export these results